M. Boldizsár

Comparison of prognostic significance of serum 5-S-Cysteinyldopa, LDH and S-100B protein in Stage III–IV malignant melanoma

Teodóra Bánfalvi, M. Boldizsár, M. Gergye et al. · Pathology & Oncology Research · 2002 · 41 citations

Medicine, Oncology, Pathology +13

Liquid chromatographic and mass spectrometric analysis of human serum acid alpha‐1‐glycoprotein

T. Kremmer, Eva Szöllösi, M. Boldizsár et al. · Biomedical Chromatography · 2004 · 37 citations

Life Sciences, Biochemistry, Oncology +16

Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma

Teodóra Bánfalvi, Katalin Gilde, M. Gergye et al. · European Journal of Cancer · 2002 · 29 citations

Medicine, Clinical Sciences, Oncology +16

Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives

Gábor Mező, András Czajlik, Marilena Manea et al. · Peptides · 2007 · 27 citations

Life Sciences, Biochemistry, Pharmacology +17

Serum concentration of 5‐S‐cysteinyldopa in patients with melanoma

Teodóra Bánfalvi, Katalin Gilde, M. Boldizsár et al. · European Journal of Clinical Investigation · 2000 · 24 citations

Medicine, Dermatology, Oncology +16